Business

Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026

Company to hold a conference call at 8:30 a.m. ETDURHAM, N.C., May 01, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced it will report first quarter 2026 financial results on Thursday, May 14, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern time. Details for the conference

articlePelthos Therapeutics Inc.May 1, 20261/company/pelthos-therapeutics-inc/news/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026

About this update from Pelthos Therapeutics Inc.

[{"type":"image","alt":"Pelthos Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Pelthos Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":179,"url":"https://media.zenfs.com/en/globenewswire.com/f94dd4c648565b20de109cac2516c355"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/k8zUsCvFBhGI4FW3YV9omg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI1MQ--/https://media.zenfs.com/en/globenewswire.com/f94dd4c648565b20de109cac2516c355","width":300,"height":179}},"lazy":false},{"type":"text","content":"Company to hold a conference call at 8:30 a.m. ET","length":49,"tagName":"p"},{"type":"text","content":"DURHAM, N.C., May 01, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced it will report first quarter 2026 financial results on Thursday, May 14, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern time.","length":424,"tagName":"p"},{"type":"text","content":"Details for the conference call can be found below:","length":51,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:50.0898%;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"width:50.0898%;","val":[{"type":"text","content":"Thursday, May 14, 2026","length":22,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:50.0898%;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"style":"width:50.0898%;","val":[{"type":"text","content":"8:30 a.m. Eastern Time","length":22,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:50.0898%;","val":[{"type":"text","content":"Toll Free:","length":10,"tagName":"p","attribs":{}}]},{"style":"width:50.0898%;","val":[{"type":"text","content":"1-877-451-6152","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:50.0898%;","val":[{"type":"text","content":"International:","length":14,"tagName":"p","attribs":{}}]},{"style":"width:50.0898%;","val":[{"type":"text","content":"1-201-389-0879","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:50.0898%;","val":[{"type":"text","content":"Conf. ID:","length":9,"tagName":"p","attribs":{}}]},{"style":"width:50.0898%;","val"...

More updates from Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.biopharmaceutical companypatient needsconference call